Motilal Oswal's research report on Jyothy Laboratories
Jyothy Laboratories (JYL) reported an in-line sales at INR 6.7b, a growth of 11% YoY (four-year CAGR at 13.6%). Volume growth stood at 11% YoY. Fabric care sustained double-digit growth (12%); healthy demand seen in the mid-price detergent powder. Dishwashing growth was slightly slow at 7%, after clocking a double-digit growth in 1HFY24, driven by competition from local or regional players. HI remained weak at 5% YoY growth; fouryear CAGR stood at 2%. Gross margin tailwinds continued; GM was up 650/50bp YoY/QoQ to 50%. Thereby, EBITDA margin saw an improvement of 350bp to 17.5% (continue to enjoy historically best margin). We model 10%/11% revenue/EBITDA CAGR over FY24-26E. With a stable RM basket, we expect EBITDA margin to sustain at 17-18%. We believe a large part of GM led earnings growth witnessed in 9MFY24 will be normalized in FY25.
Outlook
Here onwards, market share gain and success of new launches will be critical drivers for earnings growth. With rich valuation, we maintain our Neutral rating with a TP of INR 500 on 40x Dec’25E.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!